凱文股市小鱼 personal page - To The Moon

凱文股市小鱼

凱文股市小鱼

No personal profile

590Follow

28Followers

2Topic

0Badge

凱文股市小鱼

2021-09-23

$英偉達(NVDA)$Nice

凱文股市小鱼

2021-08-31

Great

Moderna shares rose more than 2% in early trading

凱文股市小鱼

2021-08-31

????

@吴彦祖白银分祖:$富途控股(FUTU)$別人恐懼我貪婪。反正不玩短期

凱文股市小鱼

2021-08-22

I got you

Sorry, the original content has been removed

凱文股市小鱼

2021-08-20

$Tiger Brokers(TIGR)$There it goes tonight ??

凱文股市小鱼

2021-08-19

$Tiger Brokers(TIGR)$13+ tonight

凱文股市小鱼

2021-08-18

$Tiger Brokers(TIGR)$14+ today

凱文股市小鱼

2021-08-16

$Tiger Brokers(TIGR)$14+ my friends

凱文股市小鱼

2021-08-13

$Tiger Brokers(TIGR)$Today should stay around 17+

凱文股市小鱼

2021-08-12

$Tiger Brokers(TIGR)$Yet another downtrend night

凱文股市小鱼

2021-08-11

$Tiger Brokers(TIGR)$Another downtrend night? stay around 17+ tonight will ya?

凱文股市小鱼

2021-08-10

$Tiger Brokers(TIGR)$downtrend night

凱文股市小鱼

2021-08-05

$Facebook(FB)$Would like to have some but it’s too pricey

凱文股市小鱼

2021-08-04

$Tiger Brokers(TIGR)$Let’s go?

凱文股市小鱼

2021-08-02

$Tiger Brokers(TIGR)$A bullish night pals

凱文股市小鱼

2021-08-02

No biggie

@Mins273:$Tiger Brokers(TIGR)$sharing

凱文股市小鱼

2021-08-01

Nice

@Todkie:$TIGR 20210820 17.5 CALL(TIGR)$Pocket money ?

凱文股市小鱼

2021-07-30

$Tiger Brokers(TIGR)$Should be staying at 16+ today.. a bit higher than yesterday

凱文股市小鱼

2021-07-30

$Tiger Brokers(TIGR)$Looks like it will stay at around 16+ today

凱文股市小鱼

2021-07-28

$Tiger Brokers(TIGR)$It’s a bullish night tonight

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3569477514028845","uuid":"3569477514028845","gmtCreate":1606383491710,"gmtModify":1622096101024,"name":"凱文股市小鱼","pinyin":"凱wgsxy凱wengushixiaoyu","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":28,"headSize":590,"tweetSize":73,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":112,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.02","exceedPercentage":"80.32%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"cbe1c45c584340f3bd9ae6c77e0e9981-1","templateUuid":"cbe1c45c584340f3bd9ae6c77e0e9981","name":"Academy Experiencer","description":"5 lessons learned","bigImgUrl":"https://community-static.tradeup.com/news/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://community-static.tradeup.com/news/c2660a1935bd2105e97c9915619936c3","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.42%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":6,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":863228654,"gmtCreate":1632400558578,"gmtModify":1676530772787,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$英偉達(NVDA)$</a>Nice","listText":"<a href=\"https://laohu8.com/S/NVDA\">$英偉達(NVDA)$</a>Nice","text":"$英偉達(NVDA)$Nice","images":[{"img":"https://static.tigerbbs.com/7100bba0a97b6fc699f112427eaa3771","width":"1125","height":"3316"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863228654","isVote":1,"tweetType":1,"viewCount":850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":818556404,"gmtCreate":1630421238008,"gmtModify":1676530299698,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818556404","repostId":"1165958269","repostType":4,"repost":{"id":"1165958269","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1630418022,"share":"https://ttm.financial/m/news/1165958269?lang=&edition=fundamental","pubTime":"2021-08-31 21:53","market":"us","language":"en","title":"Moderna shares rose more than 2% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1165958269","media":"Tiger Newspress","summary":"Moderna shares rose more than 2% in early trading.\n\n\nA study examining the immune response of Modern","content":"<p>Moderna&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;2%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e3a6617d6ec5a20d69a181840ef582fb\" tg-width=\"885\" tg-height=\"634\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>A study examining the immune response of Moderna's&nbsp;COVID-19 vaccine to Pfizer&nbsp;/BioNTech's&nbsp;found that the former created more than twice as many antibodies as the latter.</li>\n <li>The study, published in the<i>Journal of the American Medical Association</i>, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna shares rose more than 2% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna shares rose more than 2% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-31 21:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;2%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e3a6617d6ec5a20d69a181840ef582fb\" tg-width=\"885\" tg-height=\"634\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>A study examining the immune response of Moderna's&nbsp;COVID-19 vaccine to Pfizer&nbsp;/BioNTech's&nbsp;found that the former created more than twice as many antibodies as the latter.</li>\n <li>The study, published in the<i>Journal of the American Medical Association</i>, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165958269","content_text":"Moderna shares rose more than 2% in early trading.\n\n\nA study examining the immune response of Moderna's COVID-19 vaccine to Pfizer /BioNTech's found that the former created more than twice as many antibodies as the latter.\nThe study, published in theJournal of the American Medical Association, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818558414,"gmtCreate":1630421203838,"gmtModify":1676530299690,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"????","listText":"????","text":"????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818558414","repostId":"818640063","repostType":1,"repost":{"id":818640063,"gmtCreate":1630406611552,"gmtModify":1676530294226,"author":{"id":"3573802417209576","authorId":"3573802417209576","name":"吴彦祖白银分祖","avatar":"https://static.tigerbbs.com/8acc00f6ef90c3d1e911611caad9ea21","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573802417209576","authorIdStr":"3573802417209576"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FUTU\">$富途控股(FUTU)$</a>別人恐懼我貪婪。反正不玩短期","listText":"<a href=\"https://laohu8.com/S/FUTU\">$富途控股(FUTU)$</a>別人恐懼我貪婪。反正不玩短期","text":"$富途控股(FUTU)$別人恐懼我貪婪。反正不玩短期","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818640063","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":638,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832242011,"gmtCreate":1629644868133,"gmtModify":1676530085181,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"I got you","listText":"I got you","text":"I got you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/832242011","repostId":"1156125276","repostType":4,"isVote":1,"tweetType":1,"viewCount":1082,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836144249,"gmtCreate":1629467358881,"gmtModify":1676530050673,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>There it goes tonight ??","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>There it goes tonight ??","text":"$Tiger Brokers(TIGR)$There it goes tonight ??","images":[{"img":"https://static.tigerbbs.com/d64a4d2de30adde80f0747efb4dc7565","width":"1284","height":"2778"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836144249","isVote":1,"tweetType":1,"viewCount":641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":838171015,"gmtCreate":1629382919537,"gmtModify":1676530023570,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>13+ tonight&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>13+ tonight&nbsp;","text":"$Tiger Brokers(TIGR)$13+ tonight","images":[{"img":"https://static.tigerbbs.com/bdcce7863e54efa2e8090dd05af54f78","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/838171015","isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":831189410,"gmtCreate":1629294985230,"gmtModify":1676529994805,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>14+ today","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>14+ today","text":"$Tiger Brokers(TIGR)$14+ today","images":[{"img":"https://static.tigerbbs.com/2dd7abecef25ee82a04f488cec1bb819","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/831189410","isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":839111100,"gmtCreate":1629126152100,"gmtModify":1676529940344,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>14+ my friends","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>14+ my friends","text":"$Tiger Brokers(TIGR)$14+ my friends","images":[{"img":"https://static.tigerbbs.com/afd473c33a335211c8befd19453657fc","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839111100","isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":897030042,"gmtCreate":1628862166786,"gmtModify":1676529878313,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Today should stay&nbsp;around 17+","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Today should stay&nbsp;around 17+","text":"$Tiger Brokers(TIGR)$Today should stay around 17+","images":[{"img":"https://static.tigerbbs.com/f23623135147eb0de475ea2d7c2393a6","width":"1125","height":"2884"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/897030042","isVote":1,"tweetType":1,"viewCount":609,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":894910706,"gmtCreate":1628781749105,"gmtModify":1676529854664,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Yet another downtrend night&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Yet another downtrend night&nbsp;","text":"$Tiger Brokers(TIGR)$Yet another downtrend night","images":[{"img":"https://static.tigerbbs.com/a764b4a9632eeaf3d4b1ad0335bb2c89","width":"1125","height":"2884"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/894910706","isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":895033296,"gmtCreate":1628693167315,"gmtModify":1676529824263,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Another downtrend night?&nbsp;stay around&nbsp;17+ tonight will ya?","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Another downtrend night?&nbsp;stay around&nbsp;17+ tonight will ya?","text":"$Tiger Brokers(TIGR)$Another downtrend night? stay around 17+ tonight will ya?","images":[{"img":"https://static.tigerbbs.com/9a9cbf59626b88f18f73e3461d21d2de","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/895033296","isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":896768509,"gmtCreate":1628606021301,"gmtModify":1676529795636,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>downtrend night","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>downtrend night","text":"$Tiger Brokers(TIGR)$downtrend night","images":[{"img":"https://static.tigerbbs.com/9b056494e04ce7070c2edd87fe5b0ea7","width":"1125","height":"3042"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/896768509","isVote":1,"tweetType":1,"viewCount":624,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":899019086,"gmtCreate":1628141587345,"gmtModify":1703501999225,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FB\">$Facebook(FB)$</a>Would like to have some but it’s too pricey&nbsp;","listText":"<a href=\"https://laohu8.com/S/FB\">$Facebook(FB)$</a>Would like to have some but it’s too pricey&nbsp;","text":"$Facebook(FB)$Would like to have some but it’s too pricey","images":[{"img":"https://static.tigerbbs.com/55d8373c216bb9b8280274afc6b54bec","width":"1125","height":"3213"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899019086","isVote":1,"tweetType":1,"viewCount":379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":890962877,"gmtCreate":1628077455299,"gmtModify":1703500747623,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Let’s go?","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Let’s go?","text":"$Tiger Brokers(TIGR)$Let’s go?","images":[{"img":"https://static.tigerbbs.com/e04082e3c03a8dfb34b37fe40e8c74f6","width":"1125","height":"2976"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/890962877","isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":804914151,"gmtCreate":1627915854273,"gmtModify":1703497874284,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>A bullish night pals","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>A bullish night pals","text":"$Tiger Brokers(TIGR)$A bullish night pals","images":[{"img":"https://static.tigerbbs.com/99aea71c12c5e966a866214052a8c16b","width":"1125","height":"2884"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804914151","isVote":1,"tweetType":1,"viewCount":413,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805798315,"gmtCreate":1627904941737,"gmtModify":1703497551036,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"No biggie&nbsp;","listText":"No biggie&nbsp;","text":"No biggie","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805798315","repostId":"805474637","repostType":1,"repost":{"id":805474637,"gmtCreate":1627903634629,"gmtModify":1703497528783,"author":{"id":"3583218618991615","authorId":"3583218618991615","name":"Mins273","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583218618991615","authorIdStr":"3583218618991615"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>sharing","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>sharing","text":"$Tiger Brokers(TIGR)$sharing","images":[{"img":"https://static.tigerbbs.com/b2083dcd93e29cbb13e723e4fec5869d","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805474637","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805070875,"gmtCreate":1627828870097,"gmtModify":1703496356655,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805070875","repostId":"805060479","repostType":1,"repost":{"id":805060479,"gmtCreate":1627824213791,"gmtModify":1703496300231,"author":{"id":"3584090913879250","authorId":"3584090913879250","name":"Todkie","avatar":"https://static.tigerbbs.com/68110d1283e1fd53c9c0fe6ec6bccb7e","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3584090913879250","authorIdStr":"3584090913879250"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$TIGR 20210820 17.5 CALL(TIGR)$</a>Pocket money ?","listText":"<a href=\"https://laohu8.com/S/TIGR\">$TIGR 20210820 17.5 CALL(TIGR)$</a>Pocket money ?","text":"$TIGR 20210820 17.5 CALL(TIGR)$Pocket money ?","images":[{"img":"https://static.tigerbbs.com/fbfee955930a07b1487a8d06456cc422","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805060479","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":205,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806644643,"gmtCreate":1627655351882,"gmtModify":1703494256122,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Should be staying at 16+ today..&nbsp;a bit higher than yesterday&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Should be staying at 16+ today..&nbsp;a bit higher than yesterday&nbsp;","text":"$Tiger Brokers(TIGR)$Should be staying at 16+ today.. a bit higher than yesterday","images":[{"img":"https://static.tigerbbs.com/100e12489f5ce49868095073ca56478a","width":"1125","height":"3042"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806644643","isVote":1,"tweetType":1,"viewCount":192,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":808666095,"gmtCreate":1627574468917,"gmtModify":1703492757374,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Looks like it will stay at&nbsp;around 16+ today","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Looks like it will stay at&nbsp;around 16+ today","text":"$Tiger Brokers(TIGR)$Looks like it will stay at around 16+ today","images":[{"img":"https://static.tigerbbs.com/e464fb1d564291cdd0b71d08ed703a3f","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/808666095","isVote":1,"tweetType":1,"viewCount":737,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":801303491,"gmtCreate":1627481509613,"gmtModify":1703490837309,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>It’s a bullish night tonight&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>It’s a bullish night tonight&nbsp;","text":"$Tiger Brokers(TIGR)$It’s a bullish night tonight","images":[{"img":"https://static.tigerbbs.com/6935ccf69ee58c080d6e9866c3dff88a","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/801303491","isVote":1,"tweetType":1,"viewCount":306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":832242011,"gmtCreate":1629644868133,"gmtModify":1676530085181,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"I got you","listText":"I got you","text":"I got you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/832242011","repostId":"1156125276","repostType":4,"repost":{"id":"1156125276","kind":"news","pubTimestamp":1629603613,"share":"https://ttm.financial/m/news/1156125276?lang=&edition=fundamental","pubTime":"2021-08-22 11:40","market":"us","language":"en","title":"Who is Cathie Wood? What you should know Ark Invest's ace stock picker","url":"https://stock-news.laohu8.com/highlight/detail?id=1156125276","media":"MoneyWise","summary":"Move over, Warren Buffett. There’s a new oracle in town.\nLast year, Cathie Wood, founder of asset ma","content":"<p>Move over, Warren Buffett. There’s a new oracle in town.</p>\n<p>Last year, Cathie Wood, founder of asset management firm Ark Invest, established herself as a master of the modern exchange-traded fund (ETF). In 2020, her flagship Ark Innovation ETF (ARKK) posted eye-watering gains of 153%, easily crushing the return of the overall stock market.</p>\n<p>Over the past five years, ARKK has averaged an annual return of greater than 40%.</p>\n<p>While ARKK and another of the company’s funds, Ark Genomic Revolution ETF (ARKG), have struggled this year, money from investors continues to pour in and CEOs like Elon Musk want to be on her podcast. You may even have Ark fundsin your portfolio.</p>\n<p>Despite the choppy road Wood's offerings have bumped along in the past few months, investors continue to hold on. Here's why.</p>\n<p><b>Just who is Cathie Wood?</b></p>\n<p>When she founded Ark Invest in 2014, Wood had already amassed 40 years of experience researching and investing in innovation. She managed over $5 billion in assets at AllianceBernstein and over $800 million at hedge fund Tupelo Capital Management, which she also founded.</p>\n<p>Wood launched Ark as a means of packaging active stock portfolios in an ETF format.</p>\n<p>By concentrating on innovative, disruptive technologies, Arkinvests in companieswith the potential for both explosive short-term growth and long-term relevance. As the company’s CIO and portfolio manager, the final call on Ark’s investment decisions is Wood’s to make.</p>\n<p>Wood has received plenty of recognition for her investment performance in recent years.</p>\n<p>She was a featured speaker at the World Economic Forum (China) in 2016 and 2017. In 2018, she was selected by Bloomberg as one of the 50 people defining global business. In 2019,<i>Fortune</i>chose Wood to be one of the experts included in the publication’s annual<i>Fortune Investors Guide</i>.</p>\n<p>As of Aug. 11,<i>Forbes</i>estimated Wood’s net worth to be $400 million.</p>\n<p><b>Investment philosophy and performance</b></p>\n<p>Ark Invest describes its sole focus as “disruptive innovation,” which allows the firm toinvest in companieswhose products and services are expected to meet the needs of a planet that’s barrelling from crisis to crisis.</p>\n<p>Ark’s big bet is that technology is the most effective solution to these crises and that a disruption-first ethos is a primary path to greater returns.</p>\n<p>“We’re all about finding the next big thing,” reads a quote from Wood on Ark Invest’s website. “Those hewing to the benchmarks, which are backwards looking, are not about the future. They are about what has worked. We’re all about what is going to work.”</p>\n<p>And Wood’s picks are most definitely working.</p>\n<p>Despite the recent sluggishness that ARKK and ARKG are experiencing, both funds have crushed the market over the past five years</p>\n<p>ARKK, which includes tech heavyweights Tesla, Zoom, Coinbase, and Shopify among others, has grown by about 450% since the summer of 2016.</p>\n<p>Meanwhile, ARKG, which targets technologies like molecular diagnostic and genetics, and holds companies such as virtual healthcare provider Teladoc Health and Regeneron Pharmaceuticals, is up roughly 340% over the same time period.</p>\n<p><b>Recent struggles providing a buying window?</b></p>\n<p>Investors who purchased either ARKK or ARKG in 2021 have had little to celebrate, with the ETFs posting year-to-date declines of 9% and 15%, respectively.</p>\n<p>With investors changing course from growth stocks to economic recovery plays this year, many of Ark’s tech-focused plays have seen their shares decline, dragging down the value of Ark’s ETFs.</p>\n<p>It’s one of the risks of the company’s relatively narrow focus.</p>\n<p>But despite the recent weakness, investors aren’t exactly losing confidence in the Ark ETFs. In fact, they’re backing Wood with even more money, suggesting they see the dip as an attractive buying opportunity.</p>\n<p>For instance, ARKK has seen nearly $5.9 billion in inflows this year, bringing its total assets under management to a whopping $22.6 billion.</p>\n<p><b>ETFs and beyond</b></p>\n<p>Purchasing Ark ETFs is easier than you think. And now might be an ideal time to do it.</p>\n<p>You can get started witha popular investing app, which offers not only ETFs, but also fractional shares. Another app allows you to build a diversified portfolio with little more than the“spare change” left over from your everyday purchases.</p>\n<p>With a little help from theright platform, you can invest alongside Cathie Wood and, hopefully, profit massively from her next set of big ideas.</p>","source":"lsy1621813427262","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Who is Cathie Wood? What you should know Ark Invest's ace stock picker</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWho is Cathie Wood? What you should know Ark Invest's ace stock picker\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-22 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/cathie-wood-know-ark-invests-221500163.html><strong>MoneyWise</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Move over, Warren Buffett. There’s a new oracle in town.\nLast year, Cathie Wood, founder of asset management firm Ark Invest, established herself as a master of the modern exchange-traded fund (ETF). ...</p>\n\n<a href=\"https://finance.yahoo.com/news/cathie-wood-know-ark-invests-221500163.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/cathie-wood-know-ark-invests-221500163.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156125276","content_text":"Move over, Warren Buffett. There’s a new oracle in town.\nLast year, Cathie Wood, founder of asset management firm Ark Invest, established herself as a master of the modern exchange-traded fund (ETF). In 2020, her flagship Ark Innovation ETF (ARKK) posted eye-watering gains of 153%, easily crushing the return of the overall stock market.\nOver the past five years, ARKK has averaged an annual return of greater than 40%.\nWhile ARKK and another of the company’s funds, Ark Genomic Revolution ETF (ARKG), have struggled this year, money from investors continues to pour in and CEOs like Elon Musk want to be on her podcast. You may even have Ark fundsin your portfolio.\nDespite the choppy road Wood's offerings have bumped along in the past few months, investors continue to hold on. Here's why.\nJust who is Cathie Wood?\nWhen she founded Ark Invest in 2014, Wood had already amassed 40 years of experience researching and investing in innovation. She managed over $5 billion in assets at AllianceBernstein and over $800 million at hedge fund Tupelo Capital Management, which she also founded.\nWood launched Ark as a means of packaging active stock portfolios in an ETF format.\nBy concentrating on innovative, disruptive technologies, Arkinvests in companieswith the potential for both explosive short-term growth and long-term relevance. As the company’s CIO and portfolio manager, the final call on Ark’s investment decisions is Wood’s to make.\nWood has received plenty of recognition for her investment performance in recent years.\nShe was a featured speaker at the World Economic Forum (China) in 2016 and 2017. In 2018, she was selected by Bloomberg as one of the 50 people defining global business. In 2019,Fortunechose Wood to be one of the experts included in the publication’s annualFortune Investors Guide.\nAs of Aug. 11,Forbesestimated Wood’s net worth to be $400 million.\nInvestment philosophy and performance\nArk Invest describes its sole focus as “disruptive innovation,” which allows the firm toinvest in companieswhose products and services are expected to meet the needs of a planet that’s barrelling from crisis to crisis.\nArk’s big bet is that technology is the most effective solution to these crises and that a disruption-first ethos is a primary path to greater returns.\n“We’re all about finding the next big thing,” reads a quote from Wood on Ark Invest’s website. “Those hewing to the benchmarks, which are backwards looking, are not about the future. They are about what has worked. We’re all about what is going to work.”\nAnd Wood’s picks are most definitely working.\nDespite the recent sluggishness that ARKK and ARKG are experiencing, both funds have crushed the market over the past five years\nARKK, which includes tech heavyweights Tesla, Zoom, Coinbase, and Shopify among others, has grown by about 450% since the summer of 2016.\nMeanwhile, ARKG, which targets technologies like molecular diagnostic and genetics, and holds companies such as virtual healthcare provider Teladoc Health and Regeneron Pharmaceuticals, is up roughly 340% over the same time period.\nRecent struggles providing a buying window?\nInvestors who purchased either ARKK or ARKG in 2021 have had little to celebrate, with the ETFs posting year-to-date declines of 9% and 15%, respectively.\nWith investors changing course from growth stocks to economic recovery plays this year, many of Ark’s tech-focused plays have seen their shares decline, dragging down the value of Ark’s ETFs.\nIt’s one of the risks of the company’s relatively narrow focus.\nBut despite the recent weakness, investors aren’t exactly losing confidence in the Ark ETFs. In fact, they’re backing Wood with even more money, suggesting they see the dip as an attractive buying opportunity.\nFor instance, ARKK has seen nearly $5.9 billion in inflows this year, bringing its total assets under management to a whopping $22.6 billion.\nETFs and beyond\nPurchasing Ark ETFs is easier than you think. And now might be an ideal time to do it.\nYou can get started witha popular investing app, which offers not only ETFs, but also fractional shares. Another app allows you to build a diversified portfolio with little more than the“spare change” left over from your everyday purchases.\nWith a little help from theright platform, you can invest alongside Cathie Wood and, hopefully, profit massively from her next set of big ideas.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1082,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897030042,"gmtCreate":1628862166786,"gmtModify":1676529878313,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Today should stay&nbsp;around 17+","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Today should stay&nbsp;around 17+","text":"$Tiger Brokers(TIGR)$Today should stay around 17+","images":[{"img":"https://static.tigerbbs.com/f23623135147eb0de475ea2d7c2393a6","width":"1125","height":"2884"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/897030042","isVote":1,"tweetType":1,"viewCount":609,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":808666095,"gmtCreate":1627574468917,"gmtModify":1703492757374,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Looks like it will stay at&nbsp;around 16+ today","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Looks like it will stay at&nbsp;around 16+ today","text":"$Tiger Brokers(TIGR)$Looks like it will stay at around 16+ today","images":[{"img":"https://static.tigerbbs.com/e464fb1d564291cdd0b71d08ed703a3f","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/808666095","isVote":1,"tweetType":1,"viewCount":737,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":839111100,"gmtCreate":1629126152100,"gmtModify":1676529940344,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>14+ my friends","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>14+ my friends","text":"$Tiger Brokers(TIGR)$14+ my friends","images":[{"img":"https://static.tigerbbs.com/afd473c33a335211c8befd19453657fc","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839111100","isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":806644643,"gmtCreate":1627655351882,"gmtModify":1703494256122,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Should be staying at 16+ today..&nbsp;a bit higher than yesterday&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Should be staying at 16+ today..&nbsp;a bit higher than yesterday&nbsp;","text":"$Tiger Brokers(TIGR)$Should be staying at 16+ today.. a bit higher than yesterday","images":[{"img":"https://static.tigerbbs.com/100e12489f5ce49868095073ca56478a","width":"1125","height":"3042"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806644643","isVote":1,"tweetType":1,"viewCount":192,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":115498517,"gmtCreate":1623026068539,"gmtModify":1704194442583,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>?’s&nbsp;predict the market is a new fun game to take part in. Rather entertaining one??","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>?’s&nbsp;predict the market is a new fun game to take part in. Rather entertaining one??","text":"$Tiger Brokers(TIGR)$?’s predict the market is a new fun game to take part in. Rather entertaining one??","images":[{"img":"https://static.tigerbbs.com/ae9d9a262d31675bdf1553eeacd40e9a","width":"1284","height":"2778"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/115498517","isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":176667221,"gmtCreate":1626880823963,"gmtModify":1703479926212,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Quick boarding the ride mates&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Quick boarding the ride mates&nbsp;","text":"$Tiger Brokers(TIGR)$Quick boarding the ride mates","images":[{"img":"https://static.tigerbbs.com/e6bddd1430d7eed97c8d176f2b7e8849","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176667221","isVote":1,"tweetType":1,"viewCount":378,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":166876003,"gmtCreate":1624004216902,"gmtModify":1703826302221,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"A lot of sayings about this vaccines","listText":"A lot of sayings about this vaccines","text":"A lot of sayings about this vaccines","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166876003","repostId":"1176081814","repostType":4,"repost":{"id":"1176081814","kind":"news","pubTimestamp":1624002595,"share":"https://ttm.financial/m/news/1176081814?lang=&edition=fundamental","pubTime":"2021-06-18 15:49","market":"us","language":"en","title":"AstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=1176081814","media":"bloomberg","summary":"AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery tar","content":"<p>AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback for a shot that was meant to be the backbone of the global inoculation effort.</p>\n<p>Thailand was slated to receive and administer 6 million AstraZeneca vaccine doses in June but health authorities this week said they would be distributing only about 3.5 million of those shots this month. Pledging to still give out 6 million doses as planned, officials appear to be making up the shortfall with millions of shots from China’sSinovac Biotech Ltd.</p>\n<p>Shipments of shots made by Siam Bioscience -- AstraZeneca’s Bangkok-based partner, which has links to the Thai royal family -- to Malaysia and the Philippines have also been delayed, though both countries say they don’t expect to be waiting for too long.</p>\n<p>The situation comes on top of delivery problems at India’sSerum Institute of India Ltd., another AstraZeneca partner, which has left developing countries from Nepal to Rwanda short of shots that were promised through the World Health Organization-backed Covax program. Siam Bioscience is AstraZeneca’s sole Covid vaccine partner in Southeast Asia, a region that is trailing on inoculation and where the virus continues to flare, including in Thailand where infections have surged over the past two months.</p>\n<p>AstraZeneca declined to comment, while Siam BioScience didn’t respond to requests for comment.</p>\n<p>The Philippines now expects a batch of nearly 1.2 million AstraZeneca shots to be shipped from Thailand in mid-July rather than this month, though a government official saidthe initial delaywill not derail the country’s vaccination push. In Malaysia, authorities say they’re working to resolve the issues around the delivery schedule, which the government stated in May would see 610,000 doses arrive from Thailand in June and another 410,000 in July.</p>\n<p>AstraZeneca itself is also facing legal action from the European Union for a production shortfall, with the company only delivering 30 million doses to the bloc in the first quarter, compared with an original target of 120 million.</p>\n<p>Seeking Alternatives</p>\n<p>The Anglo-Swedish company, which partnered with the University of Oxford on the vaccine, received orders to supply as many as 3 billion doses worldwide before efficacy data came out last year, more than twice as many as any other first wave shot, data compiled by Bloomberg shows.</p>\n<p>While not exclusive to AstraZeneca, the various delays -- particularly out of India, which has banned the export of Covid vaccines -- have left dozens of countries that were counting on the shot desperate to find doses elsewhere, and undermined the company’s bid to supply the developing world.</p>\n<p>Now, countries are turning to alternatives, particularly shots developed by Chinese companies Sinovac and Sinopharm that recently received approval from the WHO. While they’re less effective than the Messenger RNA vaccines made by Pfizer Inc., BioNTech SE and Moderna Inc., these shots are easier to store and transport.</p>\n<p>Thailand, which aims to vaccinate70% of its populationby the end of this year, is also now allowing regional health authorities to extend the interval between Astrazeneca vaccine doses to 16 weeks, from 10 to 12 weeks previously, though officials say the move is to optimize the shot’s effectiveness and not for lack of supply.</p>\n<p>The country has alsoordered20 million doses of the Pfizer-BioNTech vaccine and isin talksfor 5 million doses of the single-shot Johnson &amp; Johnson vaccine as it continues to expect deliveries of the Astra shots from Siam Bioscience.</p>\n<p>New to Vaccine-making</p>\n<p>AstraZeneca’s vaccine is among the cheapest of the first round of Covid shots because the company said it wouldn’t take a profit, selling it at cost.</p>\n<p>But the lack of economic incentives could have constrained AstraZeneca and its manufacturing partners’ ability to get the supply chain in order, said Carlos Cordon, a professor of strategy and supply chain management at the Institute for Management Development in Lausanne, Switzerland.</p>\n<p>“The supply chain of the Astra vaccine is not an easy one and, logically, one would assume that there will be more than one source of supply to avoid bottlenecks,” Cordon said. “A little bit of an economic incentive would have certainly helped to make companies in the supply chain even eager to make higher production volumes.”</p>\n<p>AstraZeneca’s choice of Thai partner raised questions from the start. Unlike India’s Serum -- which was the world’s biggest vaccine maker before the pandemic -- and other Asia partners like South Korea’sSK Bioscience Co., Siam Bioscience is new to the vaccine-making business.</p>\n<p>The company was founded in 2009 as Thailand’s first domestic bio-pharmaceutical drugmaker by the father of the nation’s current King Maha Vajiralongkorn, to provide cheaper alternatives to imported drugs. It has also made Covid test kits.</p>\n<p>It’s set up by theCrown Property Bureau, an agency that managed assets for the palace no matter who sat on the throne. The company had been operating at a loss in the four years leadingup tothe year of pandemic, when it brought in anet profitof 35.8 million baht ($1.1 million), according to data published by the Department of Business Development.</p>\n<p>In February, Thai Prime Minister Prayuth Chan-Ocha said Siam Bioscience does not seek to profit from making the Astra vaccines.</p>\n<p>Royal Links</p>\n<p>Complicating matters is Thailand’s lese majeste law, which can see jail time ofup to15 years for defaming the royal family. Its sweeping mandate means that little is said publicly about Siam Bioscience, even as concerns over vaccine supplies grow.</p>\n<p>In January, Thai officialssaidthat Siam Bioscience would make 200 million doses each year. They haven’t spoken publicly again about the company in detail since.</p>\n<p>When former prime-ministerial candidate Thanathorn Juangroongruangkit suggested that Siam Bioscience’s royal ties played a role in its appointment as AstraZeneca’s partner, the high-profile government critic waschargedwith royal defamation.</p>\n<p>Prime Minister Prayuthapologizedthis week to the public for the delay, blaming “supply and distribution issues” without elaborating. Neither the Thai government nor Siam Bioscience responded to repeated requests for information on what is causing the supply shortfalls.</p>\n<p>One Thaihealthcareindustry veteran, who asked not to be identified for fear of legal repercussions, likened the situation with Siam Bioscience to a bakery that just started making bread.</p>\n<p>“They still haven’t perfected their craft,” he said. “None of us really knows their production capacity because they haven’t publicized it and we can’t criticize it. No one is willing to say. They can’t say it, because it’s Siam Bioscience.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 15:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-18/astrazeneca-vaccine-faces-more-supply-hurdles-now-from-thailand?srnd=premium-asia><strong>bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-18/astrazeneca-vaccine-faces-more-supply-hurdles-now-from-thailand?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-18/astrazeneca-vaccine-faces-more-supply-hurdles-now-from-thailand?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176081814","content_text":"AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback for a shot that was meant to be the backbone of the global inoculation effort.\nThailand was slated to receive and administer 6 million AstraZeneca vaccine doses in June but health authorities this week said they would be distributing only about 3.5 million of those shots this month. Pledging to still give out 6 million doses as planned, officials appear to be making up the shortfall with millions of shots from China’sSinovac Biotech Ltd.\nShipments of shots made by Siam Bioscience -- AstraZeneca’s Bangkok-based partner, which has links to the Thai royal family -- to Malaysia and the Philippines have also been delayed, though both countries say they don’t expect to be waiting for too long.\nThe situation comes on top of delivery problems at India’sSerum Institute of India Ltd., another AstraZeneca partner, which has left developing countries from Nepal to Rwanda short of shots that were promised through the World Health Organization-backed Covax program. Siam Bioscience is AstraZeneca’s sole Covid vaccine partner in Southeast Asia, a region that is trailing on inoculation and where the virus continues to flare, including in Thailand where infections have surged over the past two months.\nAstraZeneca declined to comment, while Siam BioScience didn’t respond to requests for comment.\nThe Philippines now expects a batch of nearly 1.2 million AstraZeneca shots to be shipped from Thailand in mid-July rather than this month, though a government official saidthe initial delaywill not derail the country’s vaccination push. In Malaysia, authorities say they’re working to resolve the issues around the delivery schedule, which the government stated in May would see 610,000 doses arrive from Thailand in June and another 410,000 in July.\nAstraZeneca itself is also facing legal action from the European Union for a production shortfall, with the company only delivering 30 million doses to the bloc in the first quarter, compared with an original target of 120 million.\nSeeking Alternatives\nThe Anglo-Swedish company, which partnered with the University of Oxford on the vaccine, received orders to supply as many as 3 billion doses worldwide before efficacy data came out last year, more than twice as many as any other first wave shot, data compiled by Bloomberg shows.\nWhile not exclusive to AstraZeneca, the various delays -- particularly out of India, which has banned the export of Covid vaccines -- have left dozens of countries that were counting on the shot desperate to find doses elsewhere, and undermined the company’s bid to supply the developing world.\nNow, countries are turning to alternatives, particularly shots developed by Chinese companies Sinovac and Sinopharm that recently received approval from the WHO. While they’re less effective than the Messenger RNA vaccines made by Pfizer Inc., BioNTech SE and Moderna Inc., these shots are easier to store and transport.\nThailand, which aims to vaccinate70% of its populationby the end of this year, is also now allowing regional health authorities to extend the interval between Astrazeneca vaccine doses to 16 weeks, from 10 to 12 weeks previously, though officials say the move is to optimize the shot’s effectiveness and not for lack of supply.\nThe country has alsoordered20 million doses of the Pfizer-BioNTech vaccine and isin talksfor 5 million doses of the single-shot Johnson & Johnson vaccine as it continues to expect deliveries of the Astra shots from Siam Bioscience.\nNew to Vaccine-making\nAstraZeneca’s vaccine is among the cheapest of the first round of Covid shots because the company said it wouldn’t take a profit, selling it at cost.\nBut the lack of economic incentives could have constrained AstraZeneca and its manufacturing partners’ ability to get the supply chain in order, said Carlos Cordon, a professor of strategy and supply chain management at the Institute for Management Development in Lausanne, Switzerland.\n“The supply chain of the Astra vaccine is not an easy one and, logically, one would assume that there will be more than one source of supply to avoid bottlenecks,” Cordon said. “A little bit of an economic incentive would have certainly helped to make companies in the supply chain even eager to make higher production volumes.”\nAstraZeneca’s choice of Thai partner raised questions from the start. Unlike India’s Serum -- which was the world’s biggest vaccine maker before the pandemic -- and other Asia partners like South Korea’sSK Bioscience Co., Siam Bioscience is new to the vaccine-making business.\nThe company was founded in 2009 as Thailand’s first domestic bio-pharmaceutical drugmaker by the father of the nation’s current King Maha Vajiralongkorn, to provide cheaper alternatives to imported drugs. It has also made Covid test kits.\nIt’s set up by theCrown Property Bureau, an agency that managed assets for the palace no matter who sat on the throne. The company had been operating at a loss in the four years leadingup tothe year of pandemic, when it brought in anet profitof 35.8 million baht ($1.1 million), according to data published by the Department of Business Development.\nIn February, Thai Prime Minister Prayuth Chan-Ocha said Siam Bioscience does not seek to profit from making the Astra vaccines.\nRoyal Links\nComplicating matters is Thailand’s lese majeste law, which can see jail time ofup to15 years for defaming the royal family. Its sweeping mandate means that little is said publicly about Siam Bioscience, even as concerns over vaccine supplies grow.\nIn January, Thai officialssaidthat Siam Bioscience would make 200 million doses each year. They haven’t spoken publicly again about the company in detail since.\nWhen former prime-ministerial candidate Thanathorn Juangroongruangkit suggested that Siam Bioscience’s royal ties played a role in its appointment as AstraZeneca’s partner, the high-profile government critic waschargedwith royal defamation.\nPrime Minister Prayuthapologizedthis week to the public for the delay, blaming “supply and distribution issues” without elaborating. Neither the Thai government nor Siam Bioscience responded to repeated requests for information on what is causing the supply shortfalls.\nOne Thaihealthcareindustry veteran, who asked not to be identified for fear of legal repercussions, likened the situation with Siam Bioscience to a bakery that just started making bread.\n“They still haven’t perfected their craft,” he said. “None of us really knows their production capacity because they haven’t publicized it and we can’t criticize it. No one is willing to say. They can’t say it, because it’s Siam Bioscience.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":53,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182587139,"gmtCreate":1623589443521,"gmtModify":1704206676749,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"Fun activity","listText":"Fun activity","text":"Fun activity","images":[{"img":"https://static.tigerbbs.com/ee2484bb9d3df336ff77263645c01d82","width":"1284","height":"2778"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/182587139","isVote":1,"tweetType":1,"viewCount":69,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":831189410,"gmtCreate":1629294985230,"gmtModify":1676529994805,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>14+ today","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>14+ today","text":"$Tiger Brokers(TIGR)$14+ today","images":[{"img":"https://static.tigerbbs.com/2dd7abecef25ee82a04f488cec1bb819","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/831189410","isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":895033296,"gmtCreate":1628693167315,"gmtModify":1676529824263,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Another downtrend night?&nbsp;stay around&nbsp;17+ tonight will ya?","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Another downtrend night?&nbsp;stay around&nbsp;17+ tonight will ya?","text":"$Tiger Brokers(TIGR)$Another downtrend night? stay around 17+ tonight will ya?","images":[{"img":"https://static.tigerbbs.com/9a9cbf59626b88f18f73e3461d21d2de","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/895033296","isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":801303491,"gmtCreate":1627481509613,"gmtModify":1703490837309,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>It’s a bullish night tonight&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>It’s a bullish night tonight&nbsp;","text":"$Tiger Brokers(TIGR)$It’s a bullish night tonight","images":[{"img":"https://static.tigerbbs.com/6935ccf69ee58c080d6e9866c3dff88a","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/801303491","isVote":1,"tweetType":1,"viewCount":306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":121949635,"gmtCreate":1624451494428,"gmtModify":1703837051476,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"Time will tell","listText":"Time will tell","text":"Time will tell","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121949635","repostId":"1145825451","repostType":4,"repost":{"id":"1145825451","kind":"news","pubTimestamp":1624433586,"share":"https://ttm.financial/m/news/1145825451?lang=&edition=fundamental","pubTime":"2021-06-23 15:33","market":"us","language":"en","title":"Why I Believe NIO Will Beat Out Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=1145825451","media":"InvestorPlace","summary":"The fact that Tesla scrapped its Model S Plaid Plus release is just part of it.Super fans of the latest and greatest high-endTesla, Inc. model received some disappointing news a week ago when CEO Elon Musk abruptly canceled the release of its highly anticipated Model S Plaid Plus with a tweet on June 6.Instead, the company has begun delivering a new Model S Plaid that has only a 390-mile range and 1,020 horsepower, though it still sprints to from 0 to 60 miles per hour in just two seconds.The go","content":"<blockquote>\n <b>The fact that Tesla scrapped its Model S Plaid Plus release is just part of it.</b>\n</blockquote>\n<p>Super fans of the latest and greatest high-end<b>Tesla, Inc.</b>(NASDAQ:<b>TSLA</b>) model received some disappointing news a week ago when CEO Elon Musk abruptly canceled the release of its highly anticipated Model S Plaid Plus with a tweet on June 6.</p>\n<p><img src=\"https://static.tigerbbs.com/b294a3604c7ba82bd19b3c70be3a4020\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\">Source: nrqemi / Shutterstock.com</p>\n<p>Musk wrote there was… “No need, as Plaid is just so good.”</p>\n<p>The Model S Plaid Plus was supposed to be the fastest, most powerful and priciest version of the company’s Model S. Priced at $149,990, it was to feature a range of 520 miles, thanks to its innovative 4680 battery cells, 1,100 horsepower and the ability to speed from 0 to 60 mph in less than two seconds.</p>\n<p>Instead, the company has begun delivering a new Model S Plaid that has only a 390-mile range and 1,020 horsepower, though it still sprints to from 0 to 60 miles per hour in just two seconds.</p>\n<p>As a way to “sugar coat” its flip flop, Tesla said the Model S Plaid is just as fast as the Model S Plaid Plus and $20,000 cheaper. Humm.</p>\n<p>This “bait and switch” has some Tesla fans worried, since they had deposits on the Model S Plaid Plus and wanted the innovative 4680 battery cells that Tesla had been touting as the key to longer range and more power. Essentially, the 4680 battery cells were the latest great Tesla development, since they were the first batteries to also be a structural component that supposedly allowed Tesla to lower the weight of its vehicles.</p>\n<p>Both the company’s Austin and Berlin manufacturing plants now under construction are supposed to also be making the 4680 batteries for new Tesla vehicles. If there is a problem with the engineering associated with utilizing the 4680 batteries or making them a structural component, then Tesla has grossly miscalculated, which is now worrying investors.</p>\n<p>Clearly something happened to delay the 4680 batteries that were supposed to provide Tesla with a competitive and engineering edge. For Tesla’s sake, I hope they figure out the problems associated with their much hyped 4680 battery cells, otherwise concerns about its two new manufacturing plants will emerge, as well as the stock losing more of its “mojo.”</p>\n<p>As someone who owns more than a few high-performance vehicles, I can tell you that the engineering geeks I know do<i>not</i>want to get a new Model S Plaid instead of a Model S Plaid Plus and will likely ask for their deposits back.</p>\n<p>What Tesla did is like Ferrari or Porsche telling its customers that one of their much-hyped new performance models is now not being sold because the base model was just as good! Car fanatics, like myself, like the latest and greatest engineering tidbits, so we would rather cancel our orders versus settle for a base model.</p>\n<p>The good news for Tesla is that its China sales in May resurged to 21,936, up sharply from 11,671 in April. The company’s sales tend to spike at the end of each quarter. For example, Tesla sold 35,478 vehicles in China in March, which was the strongest month ever in China.</p>\n<p>This is raising expectations for very strong China sales in June, especially now that the Model Y is being manufactured in Shanghai. Interestingly, since most Chinese Teslas are now made with iron phosphate batteries, these vehicles have lower range than its lithium cobalt vehicles, but its iron phosphate vehicles are cheaper and now increasingly being exported to Europe.</p>\n<p>However, I’m convinced another electric vehicle (EV) company will eventually displace Tesla as the biggest manufacturer of EVs in China.</p>\n<p><b>Taking Advantage of the EV Revolution’s Profit Potential</b></p>\n<p>I’m talking about&nbsp;<b>Nio, Inc.</b>(NYSE:<b>NIO</b>). The reality is that this company is on the verge of dominating the EV market in China and Hong Kong. It’s why I put NIO on my<b><i>Platinum Growth Club</i></b>Model Portfolio back in February.</p>\n<p>The company boasts that it is the “next-generation car company,” as it designs and manufactures electric vehicles that utilize the latest technologies in connectivity, autonomous driving and artificial intelligence (AI). NIO currently offers an electric seven-seater SUV (ES8) and a five-seater electric SUV (ES6) and recently introduced an attractive electric sedan (ET7). Its vehicles utilize NOMI, an in-vehicle artificial intelligence assistant.</p>\n<p>The company is also partnering with cutting-edge chip companies like<b>NVIDIA Corporation</b>(NASDAQ:<b>NVDA</b>), another one of my<b><i>Platinum Growth Club</i></b>Model Portfolio stocks. NIO plans to use the NVIDIA DRIVE Orin system-on-a-chip for its electric vehicles that will provide autonomous driving capabilities. The NVIDIA DRIVE Orin-powered supercomputer, which is being called Adam, will be launched in the ET7 sedan in China in 2022. Announcements like this are very positive, so NIO has been stealing some of Tesla’s thunder lately.</p>\n<p>Now, it’s important to note that NIO was bailed out by the Chinese government. Last year, the Chinese government injected $1 billion and now has a 24% ownership in the company. The reality is that China wants to dominate at least five major industries by 2025, and NIO is now its ticket to dominate EV manufacturing.</p>\n<p>With the backing of the Chinese government, some Wall Street firms are eager to help NIO by issuing new debt or equity. So, I wouldn’t be surprised if NIO surpasses Tesla, which is currently number-two in China, for market share in the upcoming years.</p>\n<p>That means, if you missed Tesla’s parabolic run like I did, NIO is essentially giving us a “second chance” to make money in a potentially explosive electric vehicle company.</p>\n<p>Shares of NIO climbed nearly 13% since the company’s June 4 announcement of its May delivery report and positive analyst comments, while Tesla shares rose almost 3%. First, NIO revealed that the global chip shortage is starting to take a toll on its business. NIO only delivered 6,711 vehicles in May, or a 5.5% decline from April’s deliveries. Company management noted that deliveries were “adversely impacted for several days due to the volatility of semiconductor supply and certain logistical adjustments.”</p>\n<p>Interestingly, despite the month-to-month dip, NIO’s deliveries were still up 95.3% year-over-year. Strong demand in China even inspired a Citigroup analyst to upgrade NIO to a buy rating, as he expects demand to accelerate in the coming months.</p>\n<p>In other words, NIO represents the<b>crème de la crème</b>of EV stocks right now.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why I Believe NIO Will Beat Out Tesla</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy I Believe NIO Will Beat Out Tesla\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 15:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/why-i-believe-nio-will-beat-out-tesla/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The fact that Tesla scrapped its Model S Plaid Plus release is just part of it.\n\nSuper fans of the latest and greatest high-endTesla, Inc.(NASDAQ:TSLA) model received some disappointing news a week ...</p>\n\n<a href=\"https://investorplace.com/2021/06/why-i-believe-nio-will-beat-out-tesla/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","TSLA":"特斯拉"},"source_url":"https://investorplace.com/2021/06/why-i-believe-nio-will-beat-out-tesla/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145825451","content_text":"The fact that Tesla scrapped its Model S Plaid Plus release is just part of it.\n\nSuper fans of the latest and greatest high-endTesla, Inc.(NASDAQ:TSLA) model received some disappointing news a week ago when CEO Elon Musk abruptly canceled the release of its highly anticipated Model S Plaid Plus with a tweet on June 6.\nSource: nrqemi / Shutterstock.com\nMusk wrote there was… “No need, as Plaid is just so good.”\nThe Model S Plaid Plus was supposed to be the fastest, most powerful and priciest version of the company’s Model S. Priced at $149,990, it was to feature a range of 520 miles, thanks to its innovative 4680 battery cells, 1,100 horsepower and the ability to speed from 0 to 60 mph in less than two seconds.\nInstead, the company has begun delivering a new Model S Plaid that has only a 390-mile range and 1,020 horsepower, though it still sprints to from 0 to 60 miles per hour in just two seconds.\nAs a way to “sugar coat” its flip flop, Tesla said the Model S Plaid is just as fast as the Model S Plaid Plus and $20,000 cheaper. Humm.\nThis “bait and switch” has some Tesla fans worried, since they had deposits on the Model S Plaid Plus and wanted the innovative 4680 battery cells that Tesla had been touting as the key to longer range and more power. Essentially, the 4680 battery cells were the latest great Tesla development, since they were the first batteries to also be a structural component that supposedly allowed Tesla to lower the weight of its vehicles.\nBoth the company’s Austin and Berlin manufacturing plants now under construction are supposed to also be making the 4680 batteries for new Tesla vehicles. If there is a problem with the engineering associated with utilizing the 4680 batteries or making them a structural component, then Tesla has grossly miscalculated, which is now worrying investors.\nClearly something happened to delay the 4680 batteries that were supposed to provide Tesla with a competitive and engineering edge. For Tesla’s sake, I hope they figure out the problems associated with their much hyped 4680 battery cells, otherwise concerns about its two new manufacturing plants will emerge, as well as the stock losing more of its “mojo.”\nAs someone who owns more than a few high-performance vehicles, I can tell you that the engineering geeks I know donotwant to get a new Model S Plaid instead of a Model S Plaid Plus and will likely ask for their deposits back.\nWhat Tesla did is like Ferrari or Porsche telling its customers that one of their much-hyped new performance models is now not being sold because the base model was just as good! Car fanatics, like myself, like the latest and greatest engineering tidbits, so we would rather cancel our orders versus settle for a base model.\nThe good news for Tesla is that its China sales in May resurged to 21,936, up sharply from 11,671 in April. The company’s sales tend to spike at the end of each quarter. For example, Tesla sold 35,478 vehicles in China in March, which was the strongest month ever in China.\nThis is raising expectations for very strong China sales in June, especially now that the Model Y is being manufactured in Shanghai. Interestingly, since most Chinese Teslas are now made with iron phosphate batteries, these vehicles have lower range than its lithium cobalt vehicles, but its iron phosphate vehicles are cheaper and now increasingly being exported to Europe.\nHowever, I’m convinced another electric vehicle (EV) company will eventually displace Tesla as the biggest manufacturer of EVs in China.\nTaking Advantage of the EV Revolution’s Profit Potential\nI’m talking about Nio, Inc.(NYSE:NIO). The reality is that this company is on the verge of dominating the EV market in China and Hong Kong. It’s why I put NIO on myPlatinum Growth ClubModel Portfolio back in February.\nThe company boasts that it is the “next-generation car company,” as it designs and manufactures electric vehicles that utilize the latest technologies in connectivity, autonomous driving and artificial intelligence (AI). NIO currently offers an electric seven-seater SUV (ES8) and a five-seater electric SUV (ES6) and recently introduced an attractive electric sedan (ET7). Its vehicles utilize NOMI, an in-vehicle artificial intelligence assistant.\nThe company is also partnering with cutting-edge chip companies likeNVIDIA Corporation(NASDAQ:NVDA), another one of myPlatinum Growth ClubModel Portfolio stocks. NIO plans to use the NVIDIA DRIVE Orin system-on-a-chip for its electric vehicles that will provide autonomous driving capabilities. The NVIDIA DRIVE Orin-powered supercomputer, which is being called Adam, will be launched in the ET7 sedan in China in 2022. Announcements like this are very positive, so NIO has been stealing some of Tesla’s thunder lately.\nNow, it’s important to note that NIO was bailed out by the Chinese government. Last year, the Chinese government injected $1 billion and now has a 24% ownership in the company. The reality is that China wants to dominate at least five major industries by 2025, and NIO is now its ticket to dominate EV manufacturing.\nWith the backing of the Chinese government, some Wall Street firms are eager to help NIO by issuing new debt or equity. So, I wouldn’t be surprised if NIO surpasses Tesla, which is currently number-two in China, for market share in the upcoming years.\nThat means, if you missed Tesla’s parabolic run like I did, NIO is essentially giving us a “second chance” to make money in a potentially explosive electric vehicle company.\nShares of NIO climbed nearly 13% since the company’s June 4 announcement of its May delivery report and positive analyst comments, while Tesla shares rose almost 3%. First, NIO revealed that the global chip shortage is starting to take a toll on its business. NIO only delivered 6,711 vehicles in May, or a 5.5% decline from April’s deliveries. Company management noted that deliveries were “adversely impacted for several days due to the volatility of semiconductor supply and certain logistical adjustments.”\nInterestingly, despite the month-to-month dip, NIO’s deliveries were still up 95.3% year-over-year. Strong demand in China even inspired a Citigroup analyst to upgrade NIO to a buy rating, as he expects demand to accelerate in the coming months.\nIn other words, NIO represents thecrème de la crèmeof EV stocks right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863228654,"gmtCreate":1632400558578,"gmtModify":1676530772787,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$英偉達(NVDA)$</a>Nice","listText":"<a href=\"https://laohu8.com/S/NVDA\">$英偉達(NVDA)$</a>Nice","text":"$英偉達(NVDA)$Nice","images":[{"img":"https://static.tigerbbs.com/7100bba0a97b6fc699f112427eaa3771","width":"1125","height":"3316"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863228654","isVote":1,"tweetType":1,"viewCount":850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":818556404,"gmtCreate":1630421238008,"gmtModify":1676530299698,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818556404","repostId":"1165958269","repostType":4,"repost":{"id":"1165958269","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1630418022,"share":"https://ttm.financial/m/news/1165958269?lang=&edition=fundamental","pubTime":"2021-08-31 21:53","market":"us","language":"en","title":"Moderna shares rose more than 2% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1165958269","media":"Tiger Newspress","summary":"Moderna shares rose more than 2% in early trading.\n\n\nA study examining the immune response of Modern","content":"<p>Moderna&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;2%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e3a6617d6ec5a20d69a181840ef582fb\" tg-width=\"885\" tg-height=\"634\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>A study examining the immune response of Moderna's&nbsp;COVID-19 vaccine to Pfizer&nbsp;/BioNTech's&nbsp;found that the former created more than twice as many antibodies as the latter.</li>\n <li>The study, published in the<i>Journal of the American Medical Association</i>, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna shares rose more than 2% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna shares rose more than 2% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-31 21:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;2%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e3a6617d6ec5a20d69a181840ef582fb\" tg-width=\"885\" tg-height=\"634\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>A study examining the immune response of Moderna's&nbsp;COVID-19 vaccine to Pfizer&nbsp;/BioNTech's&nbsp;found that the former created more than twice as many antibodies as the latter.</li>\n <li>The study, published in the<i>Journal of the American Medical Association</i>, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165958269","content_text":"Moderna shares rose more than 2% in early trading.\n\n\nA study examining the immune response of Moderna's COVID-19 vaccine to Pfizer /BioNTech's found that the former created more than twice as many antibodies as the latter.\nThe study, published in theJournal of the American Medical Association, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838171015,"gmtCreate":1629382919537,"gmtModify":1676530023570,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>13+ tonight&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>13+ tonight&nbsp;","text":"$Tiger Brokers(TIGR)$13+ tonight","images":[{"img":"https://static.tigerbbs.com/bdcce7863e54efa2e8090dd05af54f78","width":"1125","height":"2963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/838171015","isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":169615357,"gmtCreate":1623832555479,"gmtModify":1703820808754,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Whopping 16.29%[Eye]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Whopping 16.29%[Eye]&nbsp;","text":"$Tiger Brokers(TIGR)$Whopping 16.29%[Eye]","images":[{"img":"https://static.tigerbbs.com/def3c48d09bb4b539b2d501b2d61c267","width":"1125","height":"3134"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/169615357","isVote":1,"tweetType":1,"viewCount":135,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":185989459,"gmtCreate":1623630496971,"gmtModify":1704207204000,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/.IXIC\">$NASDAQ(.IXIC)$</a>is&nbsp;Still going uptrend ??","listText":"<a href=\"https://laohu8.com/S/.IXIC\">$NASDAQ(.IXIC)$</a>is&nbsp;Still going uptrend ??","text":"$NASDAQ(.IXIC)$is Still going uptrend ??","images":[{"img":"https://static.tigerbbs.com/af05d248415e4495c71a21d81015c0e3","width":"1125","height":"3368"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/185989459","isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":119061034,"gmtCreate":1622509120028,"gmtModify":1704185270074,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>to the moon [Applaud]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>to the moon [Applaud]&nbsp;","text":"$Tiger Brokers(TIGR)$to the moon [Applaud]","images":[{"img":"https://static.tigerbbs.com/dfa3335c436bef67a5158c7d1d089878","width":"1125","height":"2976"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/119061034","isVote":1,"tweetType":1,"viewCount":118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":894910706,"gmtCreate":1628781749105,"gmtModify":1676529854664,"author":{"id":"3569477514028845","authorId":"3569477514028845","name":"凱文股市小鱼","avatar":"https://static.tigerbbs.com/921a5a3d954e252e38b639a10e954b73","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569477514028845","authorIdStr":"3569477514028845"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Yet another downtrend night&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Yet another downtrend night&nbsp;","text":"$Tiger Brokers(TIGR)$Yet another downtrend night","images":[{"img":"https://static.tigerbbs.com/a764b4a9632eeaf3d4b1ad0335bb2c89","width":"1125","height":"2884"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/894910706","isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}